11.01.2023 23:01:42
|
P3 Health Partners Reaffirms FY22 Outlook
(RTTNews) - P3 Health Partners Inc. (PIII) reaffirmed its full-year 2022 financial guidance and also issued an outlook for the full-year 2023.
For the full-year 2022, P3 is reaffirming the revenue guidance range of between $1.025 billion and $1.075 billion, representing a 61% to 69% increase over 2021.
The at-risk Medicare Advantage membership is still expected to be greater than 100,000 for the full-year 2022, representing a roughly 35% increase over prior year.
Adjusted EBITDA loss is expected to be between $118 million and $128 million, as previously announced.
For full-year 2023, the company expects revenue of $1.20 billion to $1.25 billion and adjusted EBITDA loss of between $40 million and $60 million.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu P3 Health Partners Inc Registered Shs -A-mehr Nachrichten
11.11.24 |
Ausblick: P3 Health Partners A öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu P3 Health Partners Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
P3 Health Partners Inc Registered Shs -A- | 0,23 | -5,06% |
|